目的 探讨放疗剂量对早期鼻腔NK/T细胞淋巴瘤预后的影响。方法 将64例早期鼻腔NK/T细胞淋巴瘤患者,根据放疗剂量大小分为<50 Gy组(n=20),51~60 Gy组(n=24)和>60 Gy组(n=20),观察比较各组局部控制率和5年生存率。结果 经随访<50 Gy组局部控制率68.5%,5年生存率42.1%。51~60 Gy组局部控制率达到82.5%,生存率达60.9%。两组对比在局部控制率和5年生存率有统计学意义(P<0.05),但51~60 Gy组和>60 Gy组对比无统计学意义。结论 以51~60 Gy剂量的放疗能保证良好的局部控制率,提高患者总生存率,建议临床在选择放疗剂量时以51~60 Gy为宜。
Abstract
Objective To study the effects of different radiotherapy doses on the early stage nasal NK/T cell lymphoma. Methods 64 patients with early stage nasal NK/T cell lymphoma undergoing radiotherapy were divided into <50 Gy group(n=20), 51-60 Gy group(n=24) and >60 Gy group(n=20), all groups were observed and their local control rate and survival rate of 5 years were compared. Results The total local control rates in the three groups were 68.5%, 82.5% and 72.2% respectively. There was significant difference in the local control rate and survival rate of 5 years between<50 Gy group and the other two groups (51-60 Gy and >60 Gy group) (P<0.05), but the differences between the two groups were not statistically significant. Conclusions 51-60 Gy doses of radiation can guarantee good local control rate, improve overall survival rate. The choice of radiation doses to 50 Gy in patients with early stage nasal NK/T cell lymphoma is appropriate, with clinical recommendations.
关键词
淋巴瘤 /
鼻腔 /
NK/T细胞淋巴瘤 /
放疗剂量 /
预后
Key words
lymphoma /
nasal cavity /
NK/T cell lymphoma /
radiotherapy /
prognosis
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] 马辉辉,张红雁,钱立庭.71例鼻腔NK/T细胞淋巴瘤放化疗效和预后因素分析[J].中华放射肿瘤学杂志,2010,23(1):107-109.[2] 邹丽芬,程庆芳.鼻腔非霍奇金淋巴瘤的治疗[J].复旦学报(科学版),2009,28(7):363-365.[3] Isobe K,Uno T,Tamaru J,et al.Extranodal natural killer/T-cellymphoma,naal type:the significance of radiotherapeutic parameters[J].Cancer,2006,106:609-615.[4] 汪 华,李晔雄,王维虎,等.早期鼻腔和韦氏环NK/T细胞淋巴瘤调强放疗的初步结果[J].中华放射肿瘤学杂志,2010,19(2):67-68.[5] Koom W S,Yang W I.Angiocentric t-CELL and NK/T-cell Lymphomas:radiotheraptic viewpoints[J].Int J Radiat Oncol Biol Phys,2004,59(4):1127-1137.[6] 张小建,蒋国梁,曹军宁.鼻腔非霍奇金淋巴瘤的综合治疗[J].中华放射肿瘤学杂志,2000,9(3):162-165.[7] 钟 睿,陈志萍,邬 蒙.Ⅰ、Ⅱ期鼻腔非霍奇金淋巴瘤的预后[J].肿瘤防治杂志,2007,8(4):416-417.